Abstract 5328: mTOR inhibitor enhances anti-tumor effect of BET bromodomain inhibitor in small cell lung cancer
Anju Kumari(Thoracic Surgery Foundation), Haobin Chen(Washington University in St. Louis), Markku Miettinen(National Institutes of Health), Keith Hughitt(National Cancer Institute), Craig J. Thomas(National Institutes of Health), David S. Schrump(National Institutes of Health), Patricia Fetsch(National Institutes of Health), Beverly A. Mock(National Institutes of Health), Lisa Gesumaria(National Cancer Institute)
Cited by 0
Related Papers
Increased demand for NAD+ relative to ATP drives aerobic glycolysis
|Molecular Cell|2020|561
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
|PLoS Genetics|2014|459